Acorah Software Products - Accounts Production 15.0.500 false true false true No description of principal activity 16 March 2023 31 March 2024 31 March 2024 14734440 Dr Vasileios Panoulas iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14734440 2023-03-15 14734440 2024-03-31 14734440 2023-03-16 2024-03-31 14734440 frs-core:CurrentFinancialInstruments 2024-03-31 14734440 frs-bus:PrivateLimitedCompanyLtd 2023-03-16 2024-03-31 14734440 frs-bus:FilletedAccounts 2023-03-16 2024-03-31 14734440 frs-bus:Micro-entities 2023-03-16 2024-03-31 14734440 frs-bus:AuditExempt-NoAccountantsReport 2023-03-16 2024-03-31 14734440 frs-bus:Director1 2023-03-16 2024-03-31
Registered number: 14734440
VPCardio Limited
Unaudited Financial Statements
For the Period 16 March 2023 to 31 March 2024
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 14734440
31 March 2024
£
Fixed assets 1,044
Current assets 58,734
Prepayments and accrued income 130
Creditors: Amounts Falling Due Within One Year (12,252 )
NET CURRENT ASSETS 46,612
TOTAL ASSETS LESS CURRENT LIABILITIES 47,656
Accruals and deferred income (1,200 )
NET ASSETS 46,456
CAPITAL AND RESERVES 46,456

Notes

1. General Information
VPCardio Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14734440 . The registered office is C/O Sharpe Medical Accounting Limited, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Vasileios Panoulas
Director
26/07/2024